// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























45280 Abstracts

Radiation‐induced cataracts

S. Barnard - European Association for Vision and Eye Research (EVER) , 2017

Therapeutic Area

Disease

Drug/Treatment

Ophthalmology (OP)

Cataract

N/A

Pars plana & ciliary sulcus drainage tubes

P. Bloom - European Association for Vision and Eye Research (EVER) , 2017

Therapeutic Area

Disease

Drug/Treatment

Ophthalmology (OP)

Glaucoma

N/A

Multimodal imaging of combined harmatoma of the retina and retinal pigment epithelium

H. Bobat - European Association for Vision and Eye Research (EVER) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Prospective comparison of global visual field indices and cluster progression in glaucoma and their relationship to structural changes

V. Bono - European Association for Vision and Eye Research (EVER) , 2017

Therapeutic Area

Disease

Drug/Treatment

Ophthalmology (OP)

Glaucoma

N/A

Attitudes of parents toward eye care in children under 7 years old in the Republic of Ireland

M. Conway - European Association for Vision and Eye Research (EVER) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Outcomes and endpoints in glaucoma

M.F. Cordeiro - European Association for Vision and Eye Research (EVER) , 2017

Therapeutic Area

Disease

Drug/Treatment

Ophthalmology (OP)

Glaucoma

N/A

ECP ‐ limbal & pars plana techniques

P. Bloom - European Association for Vision and Eye Research (EVER) , 2017

Therapeutic Area

Disease

Drug/Treatment

Ophthalmology (OP)

Cataract

N/A

Does ethnicity and foveal morphology play a role in the spatial distribution of macular pigment?

I. Ctori - European Association for Vision and Eye Research (EVER) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

What to do? Management recommendations

E. M. Damato - European Association for Vision and Eye Research (EVER) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Optimisation of novel small molecule inhibitors of SRPK1‐mediated VEGF‐A splicing through modelling of permeability properties required for trans‐scleral eye drop delivery

J. Batson - European Association for Vision and Eye Research (EVER) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Exploring molecular mechanisms underlying Fuchs endothelial corneal dystrophy and their relevance to therapeutic interventions

A. Davidson - European Association for Vision and Eye Research (EVER) , 2017

Therapeutic Area

Disease

Drug/Treatment

Ophthalmology (OP)

Fuchs corneal dystrophy

N/A

Characterizing microglia activation: a spatial statistics approach to maximize information extraction

B. Davis - European Association for Vision and Eye Research (EVER) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

carisoprodol

AD in the eye

B. Davis - European Association for Vision and Eye Research (EVER) , 2017

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Alzheimer's disease

N/A

Inflammation in relation to retinal diseases

A. Dick - European Association for Vision and Eye Research (EVER) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

IL-4

Therapeutic management of uveitis

A. Dick - European Association for Vision and Eye Research (EVER) , 2017

Therapeutic Area

Disease

Drug/Treatment

Ophthalmology (OP)

Uveitis

N/A

Pathophysiology of uveitis

A. Dick - European Association for Vision and Eye Research (EVER) , 2017

Therapeutic Area

Disease

Drug/Treatment

Ophthalmology (OP)

Uveitis

N/A

Nestin expression in primary and metastatic uveal melanoma

L. Djirackor - European Association for Vision and Eye Research (EVER) , 2017

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Uveal melanoma

N/A

A review of the nature & role of pre‐receptoral, wavelength‐selective, ocular filters in vertebrates

R. Douglas - European Association for Vision and Eye Research (EVER) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Everolimus

Simulation in flight safety ‐ what can we learn from the airline industry?

I. Dow - European Association for Vision and Eye Research (EVER) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Normal and abnormal corneal innervation

H.S. Dua - European Association for Vision and Eye Research (EVER) , 2017

Therapeutic Area

Disease

Drug/Treatment

Ophthalmology (OP)

Keratoconus

N/A

Copyright © 2026. QuantiNova All rights reserved